Effects of Synthetic Thymosin-Al and Its Analogs on Fertilizability of Human Sperm: Search for a Biologically Active, Stable Epitope

Abstract

Thymosin-αl (Tαl) and six Ted analogs were synthesized to study structure-function relationships and to search for the biologically active and stable epitope(s) that would have clinical application in the treatment of male infertility. Four of these analogs were prepared by modification/substitution of N- and C-terminal amino acids of Tal peptide, and the other two analogs were fragments having only N-16 amino acids (N-terminal) or C-14 amino acids (C-terminal), respectively, of the Tal peptide. Tal and these six analogs were tested for their effects on human sperm penetration rates in the sperm penetration assay (SPA). Tal significantly (p <. 0001) increased the penetration rates in SPA, with the strongest enhancing effect at 0.5 (ig/100 μL concentration. Of the six analogs tested only two, Tal-GIy-NH₂ and Tal-C_l4, retained the enhancing effects in SPA. None of the analogs decreased the penetration rates or affected sperm motility compared to control. The enhancing activity resides primarily in an epitope, the C-terminal 14 amino acids of Tαl. However, for maximal effect both N- and C-terminal amino acids (serine and asparagine, respectively) have to be intact and unmodified. The Tαl-Gly-NH₂ analog that had its C-terminal protected was as potent as the intact Tαl peptide. Tαl and this analog may have clinical applications in treatment of male-factor-mediated infertility.

Key Words:

• thymosin-α1
• cytokines
• sperm
• infertility